UNICA IRIS Institutional Research Information System

DEIDDA, MARTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 193.833
NA - Nord America 9.075
AS - Asia 3.580
SA - Sud America 625
AF - Africa 100
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 1
Totale 207.245
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 191.847
US - Stati Uniti d'America 8.898
SG - Singapore 1.424
CN - Cina 1.159
SE - Svezia 496
BR - Brasile 481
UA - Ucraina 463
VN - Vietnam 376
FI - Finlandia 233
DE - Germania 205
GB - Regno Unito 205
FR - Francia 162
HK - Hong Kong 119
CA - Canada 91
IN - India 79
BD - Bangladesh 74
KR - Corea 61
AR - Argentina 49
MX - Messico 45
IQ - Iraq 43
NL - Olanda 37
JP - Giappone 35
ZA - Sudafrica 33
AT - Austria 27
AU - Australia 27
ES - Italia 27
RU - Federazione Russa 26
ID - Indonesia 25
TR - Turchia 24
PH - Filippine 23
PL - Polonia 21
BE - Belgio 20
CO - Colombia 20
PK - Pakistan 19
CL - Cile 18
EC - Ecuador 18
UZ - Uzbekistan 18
MA - Marocco 17
MY - Malesia 15
EG - Egitto 14
VE - Venezuela 12
IR - Iran 11
AZ - Azerbaigian 10
PE - Perù 9
TN - Tunisia 9
CU - Cuba 8
JO - Giordania 8
KE - Kenya 7
KZ - Kazakistan 7
PY - Paraguay 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
RS - Serbia 6
AL - Albania 5
BG - Bulgaria 5
BO - Bolivia 5
IE - Irlanda 5
IL - Israele 5
OM - Oman 5
PR - Porto Rico 5
UY - Uruguay 5
CH - Svizzera 4
HR - Croazia 4
KG - Kirghizistan 4
LT - Lituania 4
NZ - Nuova Zelanda 4
CR - Costa Rica 3
DZ - Algeria 3
GR - Grecia 3
HN - Honduras 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
TW - Taiwan 3
BH - Bahrain 2
BW - Botswana 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
ET - Etiopia 2
GT - Guatemala 2
KW - Kuwait 2
LV - Lettonia 2
MD - Moldavia 2
MM - Myanmar 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CY - Cipro 1
EE - Estonia 1
Totale 207.229
Salva come PNG Salva come JPEG
Città #
Cagliari 172.333
Uta 19.040
Fairfield 909
Ashburn 741
Woodbridge 727
Singapore 669
Houston 517
Dallas 475
San Jose 435
Chandler 407
Wilmington 396
Ann Arbor 390
Seattle 349
Nyköping 343
Boardman 340
Cambridge 317
Jacksonville 249
Beijing 244
Dearborn 210
Los Angeles 144
Helsinki 139
Santa Clara 125
Council Bluffs 115
Hong Kong 109
Ho Chi Minh City 107
The Dalles 102
Nanjing 99
Boston 98
Lauterbourg 95
New York 88
Shanghai 72
Hanoi 67
Hefei 67
Dong Ket 64
Seoul 58
Buffalo 57
San Diego 56
Redwood City 50
São Paulo 49
London 41
Guangzhou 39
Shenyang 36
Toronto 34
Orem 33
Milan 32
Nanchang 32
Atlanta 31
Tokyo 31
Munich 30
Chicago 29
Tianjin 29
Hebei 26
Phoenix 26
Brooklyn 25
Frankfurt am Main 25
Nuremberg 22
Changsha 20
Da Nang 20
Jiaxing 20
Mountain View 19
Chennai 18
Baghdad 17
Jinan 17
Manchester 17
Redondo Beach 17
Rio de Janeiro 17
Warsaw 17
Norwalk 16
Brussels 15
Tashkent 15
Zhengzhou 15
Denver 14
Haiphong 14
Montreal 14
Rome 14
Wuhan 14
Auburn Hills 13
Mexico City 13
Turku 13
Amsterdam 12
Columbus 12
Kunming 12
Quartu Sant'elena 12
Vienna 12
Quito 11
Falls Church 10
Johannesburg 10
Kuala Lumpur 10
Medellín 10
Miami 10
Naples 10
Orange 10
Washington 10
Augusta 9
Belo Horizonte 9
Hải Dương 9
Lappeenranta 9
Mumbai 9
San Francisco 9
Stockholm 9
Totale 201.956
Salva come PNG Salva come JPEG
Nome #
Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers 12.924
Early ischemia identification employing 2D speckle tracking selective layers analysis during dobutamine stress echocardiography 4.375
Metabolomic approach to profile functional and metabolic changes in heart failure 4.235
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 4.182
Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension 3.942
Endodontic infection and endothelial dysfunction are associated with different mechanisms in men and women 3.881
Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance 3.564
Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease 3.539
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.478
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.405
Effects of metformin and exercise training, alone or in combination, on cardiac function in individuals with insulin resistance 3.351
Cardiovascular effects, body composition, quality of life and pain after a Zumba® fitness program in Italian overweight women 3.158
Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state 3.126
A new type of physical activity from an ancient tradition: the Sardinian folk dance "ballu sardu" 3.114
Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine 3.023
Metabolomics and heart failure: a new and promising scientific approach 2.996
Coronary Artery Disease 2.939
Altered transmural contractility in postmenopausal women affected by cardiac syndrome X 2.844
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.829
Modelling chemotherapy-induced cardiotoxicity by human pluripotent stem cells 2.762
Cardioprotection by gene therapy: review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 2.752
Metabolomic approach to redox and nitrosative reactions in cardiovascular diseases 2.716
Metabolomics, a promising approach to translational research in cardiology 2.695
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 2.549
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection 2.493
Antioxidant approach as a cardioprotective strategy in chemotherapy-induced cardiotoxicity 2.418
Effects of Metformin Treatment on Myocardial and Endothelial Function in Insulin Resistance Patients: A Metabolomic Study. 2.415
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.309
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 2.283
Women-specific predictors of cardiovascular disease risk - new paradigms 2.256
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.250
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 2.242
Inverted Takotsubo cardiomyopathy induced by dobutamine stress echocardiography with atypical presentation 2.195
Effects of an aquatic-based exercise program to improve cardiometabolic profile, quality of life, and physical activity levels in men with type 2 diabetes mellitus 2.177
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 2.175
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.163
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects 2.117
IGENDA protocol: gender differences in awareness, knowledge and perception of cardiovascular risk: an Italian multicenter study 2.110
Trastuzumab-based adjuvant chemotherapy for breast cancer: Early myocardial dysfunction detected by "speckle tracking" echocardiography (STE). 2.085
The need of a gender-corrected evidence based medicine 2.081
Could ADMA levels in young adults born preterm predict an early endothelial dysfunction? 2.023
Association of endodontic infection with detection of an initial lesion to the cardiovascular system 2.000
Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention 1.973
Metabolic pathways in heart failure correlate with impaired longitudinal global strain rate 1.941
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry 1.932
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 1.882
Bridging the mortality gap: A new challenge in percutaneous coronary intervention for patients with cancer 1.872
Early right ventricular dysfunction in highly selected (totally free from cardiovascular risk factors and other comorbidities) human immunodeficiency virus patients: A pilot study with advanced echocardiography 1.834
Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients 1.793
Gender differences in cardiology: is it time for new guidelines? 1.767
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 1.733
L’analisi metabolomica delle vie metaboliche nei pazienti affetti da scompenso cardiaco correla con lo strain rate longitudinale 1.702
Gender-specific aspects in primary and secondary prevention of cardiovascular disease 1.642
Subclinical contractility impairment in HIV-infected patients: Dependence on the class of antiretroviral drugs 1.584
Subclinical contractility impairment in HIV-infected patients varies according to class of antiretroviral drugs 1.571
Vascular damage-Coronary artery disease 1.558
Ankle-brachial index and its link to automated carotid ultrasound measurement of intima-media thickness variability in 500 Japanese coronary artery disease patients 1.545
Association of automated carotid IMT measurement and HbA1c in Japanese patients with coronary artery disease 1.525
Diastolic Function in Systemic Sclerosis Patients: A Neglected Issue? 1.522
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC) 1.505
null 1.489
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.484
null 1.471
Early Ventricular Dysfunction in Type II Diabetes: Role of Metabolic Unbalance 1.421
Altered transmural contractility in women affected by cardiac X syndrome 1.413
Metabolomics: a new era in cardiology? 1.359
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry 1.352
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment 1.322
Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects 1.309
Sex differences in congenital heart defects and genetically induced arrhythmias 1.304
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin. 1.286
Cardiotoxicity from anthracycline and cardioprotection in paediatric cancer patients 1.240
null 1.234
Late persistence of elevated levels of reactive oxygen species is associated with a progressive impairment of systolic function after treatment with epirubicin 1.178
Looking for the gender equality 1.159
Relationship between high values of HOMA-IR and cardiovascular response to metformin 1.148
Novel insights in pathophysiology of antiblastic drugs-induced cardiotoxicity and cardioprotection 1.120
Different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 1.046
Preliminary data on a cardioprotective effect of telmisartan in cancer patients treated with epirubicin 991
Impact of COVID-19 on the cardiovascular health of women: a review by the Italian Society of Cardiology Working Group on 'gender cardiovascular diseases' 967
null 944
Metabolomic approach to foetal and neonatal heart 918
Contribution of metabolomics to the understanding of nafld and nash syndromes: A systematic review 892
Cardiopulmonary and endothelial effects of metformin treatment in an insulin resistant population 808
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin 791
The Echocardiographic Parameters of Systolic Function Are Associated with Specific Metabolomic Fingerprints in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy 781
Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2 phenotypic CAPIRE study 759
null 745
Early epirubicin-induced myocardail dysfunction revealed by serial tissue doppler echocardiography (TDI). Correlation with inflammatory and oxidative stress markers 741
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 725
Metabolomic Profiles on Antiblastic Cardiotoxicity: New Perspectives for Early Diagnosis and Cardioprotection 704
La Metabolomica: una nuova era in Cardiologia. Le nostre esperienze originali nei campi dell' insufficienza cardiaca, della cardiopatia ischemica e dell' ipertensione polmonare 703
Subclinical contractility impairment in HIV-infected patients: dependence on the class of antiretroviral drugs 677
A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics 644
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 632
Gender determinants of cardiovascular risk factors and diseases 627
Cardiac effects of L-thyroxine administration in borderline hypothyroidism 626
Cardiorespiratory Fitness, Preclinical Systolic and Dyastolic Dysfunctions and HRQoL in Men with Type 2 Diabetes 605
Early Strain Rate impairment during treatment with epirubicin is associated with high levels of reactive oxygen species 601
Cardiovascular modulation during vagus nerve stimulation therapy in patients with refractory epilepsy 592
Totale 198.860
Salva come PNG Salva come JPEG
Categoria #
all - tutte 255.709
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 255.709
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.503 0 0 0 0 0 0 0 0 0 0 0 1.503
2021/20229.104 1.063 579 467 814 717 670 456 511 947 845 1.006 1.029
2022/202313.092 1.267 2.022 1.775 1.157 1.140 1.093 566 849 819 765 1.039 600
2023/202414.413 724 547 614 968 1.426 2.452 2.357 919 973 935 1.243 1.255
2024/202544.484 7.462 8.569 5.317 16.410 1.493 2.395 1.659 143 321 202 220 293
2025/20268.594 433 399 908 635 674 778 1.337 868 653 796 440 673
Totale 207.691